CClinicalTrials.gg
Status unknownNCT01525251NCMMUpdated Feb 2, 2012

Nurse Case Manager Model on Neuroblastoma Caregiver's Uncertainty

An observational study in Neuroblastoma, sponsored by National Taiwan University Hospital. Status unknown at 1 site in Taiwan. Per ClinicalTrials.gov, last updated 2012-02-02.

Sponsored by National Taiwan University Hospital · Observational

The sponsor has not verified this record recently (last verified Jan 2012), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Time perspective
Prospective
Enrollment
60
Sex
All
01

Study summary

Clinical Problem and Significance: The incidence of neuroblastoma is about 30 cases a year in Taiwan. The five-year survival rate of neuroblastom is near 50% in Taiwan. Compared to the survival rate in Western countries, the treatment in Taiwan needs more efforts to improve. According to the report from the Childhood Cancer Foundation ROC, several children with neuroblastoma did not complete their treatment and or not received the protocol. In addition to the efforts in improving protocol, the reasons for those who drop-out and do not receive complete treatment need the investigators more attention to think of.

Purpose of Study: The main purpose is to evaluate the effects of nurse case manager model on caregivers' adaptation of disease uncertainty about then child with neuroblastorna.

Methods: A longitudinal and prospective design will be used to perform this study. Questionnaire survey and chart review will be the means of data collection for the part of quantative analysis. The qualitative method , semi-structural interview , also will be used to collect data regarding caregiver's perception of social support and adaptation at the same time of self-report of questionnaires survey .There are five points of time to collect data: Baseline (A), 3 months(B) , 6 months(C), 9 months(D),1 year(E) and 1.5 year(F) after eligible subjects agree to participate in the study.

Subjects: The study will use a convenience sample. Once the caregiver's child is on has been diagnosed with neuroblastoma will be recruited in this study.

Instruments: Three Chinese versions of Mishel Uncertainty in Illness-Parent Form , the self-reported socio-demographic questionnaire will be used to collect data. Process recording will be typed once finishing interview for further analysis.

Data Analysis: Quantitative data will be analyzed using SPSS 15.0 statistical software. The data will be analyzed using descriptive statistics and inferred statistics. Content analysis and theme formation will be categorized to assist the interpretation of quantitative results.

Implication: The findings of this study will be expected of the effects of nurse care manager model on children with newoblastoma cancer survivors.

02

Conditions studied

  • Neuroblastoma

Browse trials for

Keywords

  • primary caregiver
  • neuroblastoma
  • support group
  • posttraumatic stress
  • uncertainty
03

In context

Neuroblastoma

625 studies on the registry are indexed under Neuroblastoma; 122 are open to participants now.

This study's planned enrollment of 60 is below the median of 121 across 77 observational studies indexed under Neuroblastoma.

Browse Neuroblastoma studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Caregiver of Neuroblastoma Childern

Inclusion criteria

  • Care giver of Neuroblastoma Children

Exclusion criteria

Exclusion Criteria:

  • NA
05

Study design

Time perspective
Prospective
Enrollment
60 participants (estimated)
06

Study locations

1 of 1 sites recruiting
  • National Taiwan University Hospital
    Taipei, 100, Taiwan
    Recruiting
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 2, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT01525251
Lead sponsor
National Taiwan University Hospital
Collaborators
National Science Council, Taiwan, National Taiwan University
Responsible party
National Taiwan University Hospital (Associate Professor, National Taiwan University Hospital) — Principal investigator
First posted
Feb 2, 2012
Start date
Aug 2009
Last update
Feb 2, 2012

Study contacts

Ya-Ling Lee, RN,DNSc
Contact
yallee@ntu.edu.tw
+886-2-23123456 ext. 88422
Hsiao-Ling Chen, RN,GC,MS
Contact
hsaolene@gmail.com
+886-2-23123456 ext. 88422
Ya-Ling Lee, RN,DNSc
principal investigator · National Taiwan University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion